Nitroglycerin Transdermal Infusion System Patch
NDC Package 43598-893-30
Package Information
Nitroglycerin Transdermal Infusion System (nitroglycerin) patches is a medication used to relieve chest pain (angina) in people that have a certain heart condition (coronary artery disease). This formulation utilizes a patch delivery system. Marketed by Dr. Reddy's Laboratories, Inc., this product is identified by NDC 43598-893 and is authorized under FDA application NDA020145.
Identification & Billing
- RxCUI: 486146 - nitroglycerin 0.6 MG/HR 24HR Transdermal System
- RxCUI: 486146 - 24 HR nitroglycerin 0.6 MG/HR Transdermal System
- RxCUI: 486146 - 24 HR NTG 0.6 MG/HR Transdermal System
- RxCUI: 486146 - 24 HR TNG 0.6 MG/HR Transdermal System
- RxCUI: 486146 - nitroglycerin 14 MG/Day 24 HR Transdermal Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43598 - Dr. Reddy's Laboratories, Inc.
- 43598-893 - Nitroglycerin Transdermal Infusion System
- 43598-893-30 - 30 POUCH in 1 BOX, UNIT-DOSE / 1 PATCH in 1 POUCH
- 43598-893 - Nitroglycerin Transdermal Infusion System
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43598-893-30 identifies a specific commercial package of 30 pouch in 1 box, unit-dose / 1 patch in 1 pouch of Nitroglycerin Transdermal Infusion System, a human prescription drug labeled by Dr. Reddy's Laboratories, Inc.. This patch is formulated for transdermal use and contains nitroglycerin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr. Reddy's Laboratories, Inc. on March 01, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to relieve chest pain (angina) in people that have a certain heart condition (coronary artery disease). It may also be used before physical activities (such as exercise, sexual activity) to help prevent chest pain. Nitroglycerin belongs to a class of drugs known as nitrates. Angina occurs when the heart muscle is not getting enough blood. This drug works by relaxing and widening blood vessels so blood can flow more easily to the heart.
How is this Dr. Reddy's Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43598089330. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.